# Qure Healthcare, LLC clinical trials: 23 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Qure Healthcare, LLC as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Qure Healthcare, LLC: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/qure-healthcare-llc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 1, 2025 | NCT07099001 | Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay | Qure Healthcare, LLC | Not applicable | Completed | Alzheimer Disease (AD), Cognitive Decline | 178 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07099001) |
| June 20, 2023 | NCT05910697 | Clinical Utility of MyProstateScore 2.0 P2 | Qure Healthcare, LLC | Not applicable | Terminated | Prostate Cancer | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05910697) |
| June 20, 2023 | NCT05910684 | Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study | Qure Healthcare, LLC | Not applicable | Completed | Cardiometabolic Syndrome | 114 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05910684) |
| January 27, 2023 | NCT05702385 | Clinical Utility Study for Exo-PDAC | Qure Healthcare, LLC | Not applicable | Withdrawn | Pancreas Cancer | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05702385) |
| December 21, 2022 | NCT05658653 | Clinical Utility of CDMT Among VillageMD Providers | Qure Healthcare, LLC | Not applicable | Completed | Chronic Disease, Drug Drug Interaction, Medication Adherence | 166 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05658653) |
| November 2, 2022 | NCT05603299 | Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test | Qure Healthcare, LLC | Not applicable | Withdrawn | Non Small Cell Lung Cancer | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05603299) |
| September 2, 2022 | NCT05525806 | Clinical Utility Study for MyProstateScore+ | Qure Healthcare, LLC | Not applicable | Completed | Prostate Cancer | 234 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05525806) |
| February 14, 2022 | NCT05237271 | Clinical Utility Trial for the SomaLogic CVD-T2D Test | Qure Healthcare, LLC | Not applicable | Completed | Cardiovascular Diseases, Type 2 Diabetes | 251 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05237271) |
| January 20, 2022 | NCT05200325 | Clinical Utility Evidence for TissueCypher® | Qure Healthcare, LLC | Not applicable | Completed | Gastro-Intestinal Disorder, Barrett Esophagus | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05200325) |
| January 14, 2022 | NCT05192590 | Establishing Clinical Utility Evidence for Chronic Disease Management Testing | Qure Healthcare, LLC | Not applicable | Completed | Cardiometabolic Syndrome | 247 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05192590) |
| January 5, 2021 | NCT04693793 | Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath | Qure Healthcare, LLC | Not applicable | Completed | Dyspnea, Unexplained Chronic Dyspnea | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04693793) |
| September 16, 2020 | NCT04550416 | Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study | Qure Healthcare, LLC | Not applicable | Completed | Prostate Cancer | 217 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04550416) |
| February 12, 2020 | NCT04266860 | Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients | Qure Healthcare, LLC | Not applicable | Completed | Lupus Nephritis, Lupus Erythematosus, Systemic | 166 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04266860) |
| February 12, 2020 | NCT04266834 | Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization | Qure Healthcare, LLC | Not applicable | Completed | AKI, Contrast-induced Nephropathy | 157 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04266834) |
| February 12, 2020 | NCT04266821 | Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Trial | Qure Healthcare, LLC | Not applicable | Completed | Pain, Pain, Chronic | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04266821) |
| December 18, 2019 | NCT04204018 | Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia | Qure Healthcare, LLC | Not applicable | Completed | Pre-Eclampsia | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04204018) |
| September 6, 2019 | NCT04080037 | Assessing Opioid Care Practices Using CPV Patient Simulation Modules | Qure Healthcare, LLC | Not applicable | Completed | Pain, Pain, Acute, Pain, Chronic, Pain, Neuropathic, Opioid-use Disorder, Opioid Abuse and Addiction, Opioid Withdrawal | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04080037) |
| January 11, 2019 | NCT03800901 | Quality IQ Patient Simulation Physician Practice Measurement and Engagement | Qure Healthcare, LLC | Not applicable | Completed | Diabetes, Hypertension, Depression, Osteoarthritis, Asthma, Pain, Heart Failure | 187 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03800901) |
| December 5, 2018 | NCT03765203 | Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients | Qure Healthcare, LLC | Not applicable | Completed | Transplant;Failure,Kidney | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03765203) |
| December 5, 2018 | NCT03765164 | Glucose Control Using 1,5-AG Testing | Qure Healthcare, LLC | Not applicable | Completed | Diabetes | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03765164) |
| July 10, 2018 | NCT03581994 | DDI Effectiveness and Clinical Awareness | Qure Healthcare, LLC | Not applicable | Completed | Drug-Drug Interactions | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03581994) |
| September 27, 2016 | NCT02915653 | Adult Primary and Preventive Practice (APPP) Study | Qure Healthcare, LLC | Not applicable | Completed | Preventive Care | 213 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02915653) |
| April 10, 2015 | NCT02414438 | Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study | Qure Healthcare, LLC | Not applicable | Completed | Intellectual Disability, Developmental Delay | 217 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02414438) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 23 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Withdrawn | 2 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain | 3 |
| Prostatic Neoplasms | 3 |
| Diabetes Mellitus | 2 |
| Chronic Pain | 2 |
| Metabolic Syndrome | 2 |
| Hypertension | 1 |
| Depression | 1 |
| Osteoarthritis | 1 |
| Asthma | 1 |
| Heart Failure | 1 |
| Acute Pain | 1 |
| Neuralgia | 1 |
| Opioid-Related Disorders | 1 |
| Behavior, Addictive | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Dyspnea | 1 |
| Digestive System Diseases | 1 |
| Barrett Esophagus | 1 |
| Lupus Nephritis | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Pancreatic Neoplasms | 1 |
| Pre-Eclampsia | 1 |
| Intellectual Disability | 1 |
| Learning Disabilities | 1 |
| Chronic Disease | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Media agencies in the United States](https://specstream.ai/data/businesses/media-agencies/united-states)
- [Dialysis clinics in the United States](https://specstream.ai/data/businesses/dialysis-clinics/united-states)
- [Water heater installers in the United States](https://specstream.ai/data/businesses/water-heater-installers/united-states)
- [Oncology practices in the United States](https://specstream.ai/data/businesses/oncology-practices/united-states)
- [Engineering schools in the United States](https://specstream.ai/data/businesses/engineering-schools/united-states)
- [American restaurants in the United States](https://specstream.ai/data/businesses/american-restaurants/united-states)
